Experiments for taxon Broussonetia kazinoki (MORACEAE)

289 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
212418	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETININE B
295353	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE G
10939	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIINFLAMMATORY ACTIVITY	Broussonetia kazinoki (MORACEAE)
295417	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE A
279648	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	BROUSSONOL C
231160	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL K
231148	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL D
86435	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	KAZINOL K
416102	PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY	UTERINE STIMULANT EFFECT	Broussonetia kazinoki (MORACEAE)
279660	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL F
212413	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE E
276076	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE J-2
264740	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE T
295375	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE K
295335	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE C
279659	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL F
295389	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE N
295368	PHARMACOLOGY OF COMPOUND - IN VITRO	RNA POLYMERASE INHIBITION(HORMONE-SENSITIVE)	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE J
295397	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE O
231137	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL Q
295386	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE M
295371	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE K
231159	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL K
295346	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE F
295382	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE M
1135217	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIBACTERIAL ACTIVITY	Broussonetia kazinoki (MORACEAE)
295329	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE B
295357	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE H
85427	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	KAZINOL M
251832	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE N
261155	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNOSIDASE I INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE QBROUSSONETINE OBROUSSONETINE MBROUSSONETINE P
231154	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Broussonetia kazinoki (MORACEAE)	KAZINOL K
223522	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE I
198539	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE C
295331	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE C
231143	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL R
264739	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE S
295394	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE O
279642	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	BROUSSONOL B
295354	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE G
738391	VOUCHER SPECIMEN REPORTED FOR		Broussonetia kazinoki (MORACEAE)
251833	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE N
802497	PHARMACOLOGY OF EXTRACT - IN VITRO	NITRIC OXIDE SYNTHESIS INHIBITION	Broussonetia kazinoki (MORACEAE)
295365	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE J
239190	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE K
295401	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE P
231150	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL D
295390	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE N
212406	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE A
295412	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE XBROUSSONETINE J-2BROUSSONETINE WBROUSSONETINE VBROUSSONETINE J-1BROUSSONETINE RBROUSSONETINE UBROUSSONETINE TBROUSSONETINE U-1BROUSSONETINE M-1BROUSSONETINE S
295320	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE A
212414	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE F
279664	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL J
295378	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE L
239194	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE L
279637	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONOL A
279653	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONOL E
231167	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	FLAVAN,4'-7-DIHYDROXY:
228531	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE H
261161	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCOSIDASE II INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE P
1135221	MEDICINAL FOLKLORE REPORTED FOR	ANTIECZEMA EFFECT	Broussonetia kazinoki (MORACEAE)
239187	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE K
231164	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	FLAVAN,4'-7-DIHYDROXY:
295343	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE E
820774	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)	Broussonetia kazinoki (MORACEAE)
270937	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	BROUSSONOL A
295324	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE A
228529	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE G
295405	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE P
295374	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE K
295322	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE A
231153	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL D
295383	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE M
279649	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONOL D
239192	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE L
295347	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE F
295332	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE C
231134	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL Q
295372	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE K
295328	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE B
261157	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE QBROUSSONETINE O
231161	MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Broussonetia kazinoki (MORACEAE)	FLAVAN,4'-7-DIHYDROXY:
295369	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE J
416105	PHARMACOLOGY OF EXTRACT - IN VITRO	SMOOTH MUSCLE RELAXANT ACTIVITY	Broussonetia kazinoki (MORACEAE)
279644	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	BROUSSONOL B
295423	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE B
295358	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE H
261156	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNOSIDASE II INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE M
85428	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	KAZINOL N
295336	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE D
86438	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	KAZINOL F
295396	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE O
212417	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETININE A
279655	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	BROUSSONOL E
295385	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE M
295416	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE A
1135218	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTILEUCORRHEA ACTIVITY	Broussonetia kazinoki (MORACEAE)
223523	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE J
279641	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONOL B
231165	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	FLAVAN,4'-7-DIHYDROXY:
295325	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE A
295395	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE O
231156	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL K
295355	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE G
231145	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL R
279663	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL J
279652	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	BROUSSONOL D
295391	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE N
239188	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE K
295420	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE B
295413	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE A
295366	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE J
86434	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	KAZINOL H
276075	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE J-1
295351	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE G
295380	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE L
295321	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE A
295362	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE H
261160	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNOSIDASE II INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE OBROUSSONETINE P
802496	VOUCHER SPECIMEN REPORTED FOR		Broussonetia kazinoki (MORACEAE)
228530	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE H
295373	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE K
231142	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL R
198543	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE D
231149	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL D
1135220	MEDICINAL FOLKLORE REPORTED FOR	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Broussonetia kazinoki (MORACEAE)
295340	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE D
295406	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE Q
231138	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL Q
279638	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	BROUSSONOL A
239195	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE L
239196	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE L
295344	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE E
295339	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE D
310310	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE Y
10941	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIINFLAMMATORY ACTIVITY	Broussonetia kazinoki (MORACEAE)
261153	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCOSIDASE II INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE M
264742	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE V
231141	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL R
295333	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE C
239193	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE L
276072	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE X
295424	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE B
228526	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE G
239186	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE K
295388	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE N
198542	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE D
295327	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE B
295384	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE M
231162	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	FLAVAN,4'-7-DIHYDROXY:
511041	IDENTIFICATION IN BY GLC		Broussonetia kazinoki (MORACEAE)	LINOLENIC ACIDSTEARIC ACIDPALMITIC ACIDLINOLEIC ACIDOLEIC ACID
295348	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE F
295415	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE A
231168	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Broussonetia kazinoki (MORACEAE)	KAZINOL H
261164	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNOSIDASE II INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE Q
279645	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONOL C
820777	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)	Broussonetia kazinoki (MORACEAE)
231152	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL D
295337	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE D
295377	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE L
212410	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE B
231135	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL Q
212416	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE F
228527	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE G
295359	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE H
295399	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE O
84097	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	KAZINOL P
231157	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL K
231146	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL R
261158	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCOSIDASE II INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE QBROUSSONETINE O
231166	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	FLAVAN,4'-7-DIHYDROXY:
416104	PHARMACOLOGY OF EXTRACT - IN VITRO	SMOOTH MUSCLE STIMULANT ACTIVITY	Broussonetia kazinoki (MORACEAE)
228532	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE H
276074	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE U-1
310311	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE Z
295400	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE P
820776	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)	Broussonetia kazinoki (MORACEAE)
295410	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE Q
802498	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Broussonetia kazinoki (MORACEAE)	KAZINOL B
261163	PHARMACOLOGY OF COMPOUND - IN VITRO	GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE Q
279651	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	BROUSSONOL D
1135219	MEDICINAL FOLKLORE REPORTED FOR	ESCHAROTIC EFFECT	Broussonetia kazinoki (MORACEAE)
231169	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Broussonetia kazinoki (MORACEAE)	OLEANOLIC ACID
228533	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE H
279640	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	BROUSSONOL A
86437	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	KAZINOL D
279662	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL J
85426	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	KAZINOL L
295350	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE F
295349	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE F
295338	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE D
212408	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE B
1291152	PHARMACOLOGY OF EXTRACT - IN VITRO	NEURAMINIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)
295414	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE A
295407	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE Q
295326	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE B
279639	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	BROUSSONOL A
295419	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE B
239197	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE L
295361	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE H
279636	VOUCHER SPECIMEN REPORTED FOR		Broussonetia kazinoki (MORACEAE)
295421	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE B
251835	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE N
261152	PHARMACOLOGY OF COMPOUND - IN VITRO	GLUCOSIDASE I INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE QBROUSSONETINE OBROUSSONETINE MBROUSSONETINE P
86433	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	KAZINOL G
295363	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE I
231147	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Broussonetia kazinoki (MORACEAE)	KAZINOL D
1135222	MEDICINAL FOLKLORE REPORTED FOR	APPETITE STIMULANT	Broussonetia kazinoki (MORACEAE)
212412	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE E
295334	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE C
276071	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE W
295403	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE P
295408	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE Q
279661	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Broussonetia kazinoki (MORACEAE)	KAZINOL J
279657	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Broussonetia kazinoki (MORACEAE)	KAZINOL F
295387	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE M
295418	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE A
295345	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE E
231139	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL Q
261159	PHARMACOLOGY OF COMPOUND - IN VITRO	GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE O
198540	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE C
295409	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE Q
295392	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE N
295367	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE J
86436	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	KAZINOL C
416103	PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY	UTERINE RELAXATION EFFECT	Broussonetia kazinoki (MORACEAE)
295352	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE G
279646	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	BROUSSONOL C
239189	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE K
261154	PHARMACOLOGY OF COMPOUND - IN VITRO	GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE M
198541	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDABSOLUTE CONFIGURATION DETERMINEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE D
231158	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL K
738392	PHARMACOLOGY OF EXTRACT - IN VITRO	ANGIOGENESIS INHIBITION	Broussonetia kazinoki (MORACEAE)
726620	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIADHESION EFFECT	Broussonetia kazinoki (MORACEAE)
295341	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE E
198538	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDABSOLUTE CONFIGURATION DETERMINEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE C
295330	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE B
228528	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE G
231136	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL Q
264738	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE R
295370	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE K
212419	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETININE B
295398	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE O
1135216	MEDICINAL FOLKLORE REPORTED FOR	DIURETIC ACTIVITY	Broussonetia kazinoki (MORACEAE)
295422	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE B
295376	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE L
279650	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	BROUSSONOL D
295411	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE Q
295356	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE G
943063	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)
231155	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL K
295381	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE L
251834	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE N
726619	VOUCHER SPECIMEN REPORTED FOR		Broussonetia kazinoki (MORACEAE)
231144	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL R
212411	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE D
279656	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	BROUSSONOL E
212415	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETININE A
279654	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	BROUSSONOL E
295342	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE E
231163	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	FLAVAN,4'-7-DIHYDROXY:
802499	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE SYNTHESIS INHIBITION	Broussonetia kazinoki (MORACEAE)	KAZINOL B
231151	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL D
279643	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	BROUSSONOL B
549031	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIOXIDANT ACTIVITY	Broussonetia kazinoki (MORACEAE)
231140	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	KAZINOL R
261151	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE MBROUSSONETINE P
231133	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	KAZINOL Q
212409	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE C
726621	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)
295404	PHARMACOLOGY OF COMPOUND - IN VITRO	ALPHA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE P
239191	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE K
416106	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Broussonetia kazinoki (MORACEAE)
295402	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GLUCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE P
264741	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE U
820775	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)	Broussonetia kazinoki (MORACEAE)
279658	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	KAZINOL F
295323	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE A
86432	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	KAZINOL E
295364	BIOSYNTHESISISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE J
85425	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	KAZINOL J
261162	PHARMACOLOGY OF COMPOUND - IN VITRO	GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE P
276073	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Broussonetia kazinoki (MORACEAE)	BROUSSONETINE M-1
10940	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIINFLAMMATORY ACTIVITY	Broussonetia kazinoki (MORACEAE)
295393	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-MANNOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE N
295379	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE L
279647	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Broussonetia kazinoki (MORACEAE)	BROUSSONOL C
295360	PHARMACOLOGY OF COMPOUND - IN VITRO	BETA-GALACTOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE H
212407	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCOSIDASE INHIBITION	Broussonetia kazinoki (MORACEAE)	BROUSSONETINE A

Experiments for taxon Broussonetia kazinoki (MORACEAE)

Experiments (289 results)

Filters

Worktypes (19)

Pharmacology (32)

Compounds (60)

Organisms (28)